OP 2507
Alternative Names: ONO 2507Latest Information Update: 04 Oct 2000
Price :
$50 *
At a glance
- Originator Dainippon Pharmaceutical; Ono Pharmaceutical
- Class Anti-ischaemics; Hepatoprotectants; Prostaglandins; Small molecules
- Mechanism of Action Epoprostenol agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebrovascular disorders; Liver disorders; Reperfusion injury
Most Recent Events
- 04 Oct 2000 Two preclinical studies have been added to the Transplant Rejection and Vascular Disorders pharmacodynamics sections ,
- 14 Jun 2000 Discontinued-Preclinical for Reperfusion injury in Japan (IV)
- 30 May 2000 Discontinued-II for Liver disorders prevention in Japan (IV)